CD19 and systemic lupus erythematosus: The more recent success of B cell depletion with anti-CD19 CAR-T (chimeric antigen receptor-T) cells in lupus-prone mice may offer an alternative, more successful approach for B cell depletion therapy for SLE in humans (Kansal et al., 2019).